Ms. Emma Andrews reports

NEXTLEAF SOLUTIONS COMPLETES INITIAL SOFTGEL SHIPMENT TO AUSTRALIA AND ANNOUNCES GLOBAL EXPANSION OF COMMERCIAL PARTNERS PROGRAM

Nextleaf Solutions Ltd. has expanded its commercial partners program to support global market growth through completion of an initial softgel shipment to Australia.

Nextleaf announces initial softgel shipment to Australia

In January, 2026, Nextleaf served as exporter of record for a commercial shipment of 756,000 cannabis softgels to a white-label client in Australia.

"By leveraging our core capabilities, purchasing scale, lean infrastructure and established regulatory expertise, Nextleaf streamlined the process and reinforced our role as a disciplined, capital-efficient partner within the global medical cannabis supply chain," shared Vipin Vikraman, vice-president, operations, at Nextleaf Solutions.

This transaction demonstrates the company's capabilities as a total quality producer with validated quality assurance systems, multisite operational co-ordination and an export-ready platform.

Global medical cannabis opportunity

International demand for export-ready, pharmaceutical-grade product is transitioning from dried cannabis flower to include greater emphasis on derivative products. Nextleaf is advancing its commercial partners program to enable increased access to medical cannabis through its formulated ingredients and branded product portfolio.

The global medical cannabis market size reached $39.6-billion (U.S.) in 2025, and the market is projected to reach $74.3-billion (U.S.) by 2034 (6.9-per-cent growth).

"Nextleaf is uniquely positioned to meet rising global demand through patented extraction technology and industry-leading quality, setting the standard for processing cannabis at scale," commented Emma Andrews, chief executive officer.

Built on the company's foundation as a total quality producer, Nextleaf's commercial partners program offers validated formulations, export-ready infrastructure and a scalable operating model designed to support long-term, margin-focused growth for partners across domestic and international markets.

The company's high-purity and full-spectrum cannabinoid ingredients and dose-controlled drug delivery formats include cannabis softgels, vapes and oils through its flagship brand and Canadian market leader, Glacial Gold.

Ready-to-consume, discreet and non-combustible products offer a more reliable, convenient and safe consumption experience for the enhanced confidence of patients and prescribers alike.

Nextleaf delegation to attend Australian Medicinal Cannabis Association conference

The Australian Medicinal Cannabis Association will host its annual onference "United in Compassion," Feb. 26 to Feb. 28, 2026, in Brisbane, Australia.

Australia's medical cannabis market continues to demonstrate strong growth, supported by a robust regulatory framework, increasing patient adoption and rising demand for consistent, pharmaceutical-grade formulations. As the market evolves, it has transitioned into a more structured and compliance-driven ecosystem where reliable supply, validated products and operational discipline are increasingly valued by distributors and prescribers.

Ms. Andrews will be attending the AMCA conference and is available for meetings in Sidney, Melbourne and Brisbane. Australian-based medical cannabis resellers, distributors and prospective international partners are encouraged to contact Ms. Andrews directly through LinkedIn, or through e-mail at info@nextleafsolutions.com.

About Nextleaf Solutions Ltd.

Nextleaf is a Canadian, federally licensed cannabis processor and life science company, delivering a portfolio of high-purity cannabinoid ingredients and branded derivative products at scale.

As a total quality producer, Nextleaf maintains end-to-end controls and oversight across sourcing, extraction, distillation, formulation and finished goods through a multipatented, highly automated, closed-loop system. Nextleaf holds 19 U.S. patents and over 75 patents globally covering advanced cannabinoid processing, including extraction, distillation and acetylation.

Nextleaf's house of brands includes a range of value-driven and soft-premium offerings through category-leading flagship brand Glacial Gold, High Plains Cannabis and recently launched Yard Cannabis. Distributed coast to coast across medical and recreational channels, with an emerging niche amongst wellness consumers, Nextleaf's products include good-manufacturing-practice-compliant and export-ready pharma-grade ingredients and products.

We seek Safe Harbor.